Target intelligence / Profile preview

IRX2 divergent transcript (IRX2-DT)

Target
IRX2-DT
Molecular classification
Long non-coding RNA (lncRNA), Other
01

Overview

IRX2 divergent transcript (IRX2-DT) is a human long non-coding RNA gene located on chromosome 5 near the IRX2 protein-coding gene. It is classified as a divergent transcript, meaning it is found within 300–500 nucleotides of a protein coding gene and transcribed in the opposite direction. While some basic molecular function annotation (protein binding) exists, its biological role, disease association, and relevance as a therapeutic target are not established. The numerous aliases stem from its genomic neighbourhood (e.g., IRX2 neighbor, C5orf38) and historical annotation, but the gene is presently defined as non-coding and does not encode an active receptor, enzyme, or protein. No therapeutics, biomarkers, or clinical safety issues are associated with IRX2-DT. IRX2-DT is a long non-coding RNA and is not considered a receptor or canonical therapeutic target. The current nomenclature includes repeats and ambiguous or incorrect synonyms; only the established lncRNA name applies. There is no evidence for drug interaction or disease role in curated sources.

Other names
C5orf38CEIIRX2NBIRX2 neighborcoordinated expression to IRX2Protein CEI
02

Mechanism of action

None — no mechanisms are described as IRX2-DT is not targeted by drugs.

03

Biological functions

No well-characterized biological functions have been described; some generic molecular annotations note “protein binding” (Gene Ontology term GO:0005515), but this does not indicate a specific biological pathway or established function
04

Disease associations

Other (No direct disease associations are reported in current sources.)
05

Safety considerations

None reported.
06

Interacting drugs

None — no drugs are listed as interacting with IRX2-DT
07

Biomarkers

None — it is not used as a biomarker for patient selection or efficacy monitoring

Beyond the preview

Go deeper on IRX2 divergent transcript (IRX2-DT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on IRX2 divergent transcript (IRX2-DT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call